Hot Pursuit     21-Dec-22
Zydus Lifesciences Ltd spurts 2.71%
Zydus Lifesciences Ltd is quoting at Rs 422.5, up 2.71% on the day as on 12:49 IST on the NSE. The stock is down 9.49% in last one year as compared to a 7.87% spurt in NIFTY and a 5.02% spurt in the Nifty Metal index.

Zydus Lifesciences Ltd gained for a third straight session today. The stock is quoting at Rs 422.5, up 2.71% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.52% on the day, quoting at 18290.05. The Sensex is at 61361.48, down 0.55%. Zydus Lifesciences Ltd has risen around 7.71% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has risen around 0.24% in last one month and is currently quoting at 12618.45, up 1.97% on the day. The volume in the stock stood at 16.66 lakh shares today, compared to the daily average of 7.4 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 423.6, up 2.65% on the day. Zydus Lifesciences Ltd is down 9.49% in last one year as compared to a 7.87% spurt in NIFTY and a 5.02% spurt in the Nifty Metal index.

The PE of the stock is 33.96 based on TTM earnings ending September 22.

Previous News
  Indices trade near flat line; Media shares rally
 ( Market Commentary - Mid-Session 18-May-24   10:32 )
  Zydus completes Phase II clinical study of NLRP3 inhibitor ‘Usnoflast (ZYIL1)'
 ( Corporate News - 24-May-24   16:02 )
  Zydus Life declines after US FDA concludes manufacturing facility inspection with 10 observations
 ( Hot Pursuit - 24-Apr-24   13:24 )
  Zydus Life, Torrent Pharma to co-market chronic liver diseases treatment drug in India
 ( Hot Pursuit - 10-Nov-23   15:52 )
  Zydus Lifesciences Ltd soars 1.52%, rises for fifth straight session
 ( Hot Pursuit - 11-Mar-24   13:00 )
  Zydus Lifesciences Ltd down for fifth straight session
 ( Hot Pursuit - 12-Oct-23   13:35 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Sensex up 203 pts, oil & gas shares advance
 ( Market Commentary - Mid-Session 24-Apr-24   14:36 )
  Zydus receives USFDA approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension
 ( Corporate News - 08-Jun-23   14:43 )
  Board of Zydus Lifesciences recommends Final Dividend
 ( Corporate News - 19-May-23   16:35 )
  Torrent Pharmaceuticals and Zydus enter in licensing agreement for co-marketing Saroglitazar Magnesium
 ( Corporate News - 10-Nov-23   16:04 )
Other Stories
  Eicher Motors CV sales rises 11% YoY in June’24
  01-Jul-24   15:39
  Atul Auto hits record high as sales double to 2,628 units in Jun’24
  01-Jul-24   15:29
  Ashok Leyland slides as total sales slips 2% YoY in June'24
  01-Jul-24   15:16
  Reliance Infrastructure Ltd leads losers in 'A' group
  01-Jul-24   15:00
  Oriental Carbon & Chemicals Ltd leads losers in 'B' group
  01-Jul-24   14:45
  Rane Holdings hits life high on plan to acquire 51% stake in JV
  01-Jul-24   14:45
  Maruti Suzuki rises as total sales jumps 12% YoY in Jun’24
  01-Jul-24   14:37
  Volumes jump at Emami Ltd counter
  01-Jul-24   14:30
  Karur Vysya Bank advances climb 16% YoY in Jun'24
  01-Jul-24   14:14
  SML Isuzu jumps as June sales surges 38% YoY
  01-Jul-24   14:13
Back Top